Superiority of 68Ga-DOTA-FAPI-04 PET/CT to 18F-FDG PET/CT in the evaluation of different cancers with bone metastases
<sup>68</sup>Ga-DOTA-FAPI-04 as a novel imaging agent, can detect more bone metastases and has a higher tracer uptake level than <sup>18</sup>F-FDG. Especially for lung and gastric cancer, <sup>68</sup>Ga-DOTA-FAPI-04 PET/CT may be a more reliable means to detect bone metastases.
Authors
- Hua Su
- Qing Xie
- Zhi Yang (ORCID: https://orcid.org/0000-0003-2084-5193)
- Xiangxi Meng (ORCID: https://orcid.org/0000-0002-6590-011X)
- Wei Zhao (ORCID: https://orcid.org/0000-0002-6182-4746)
- Nan Li (ORCID: https://orcid.org/0000-0001-8619-7550)
- Fei Wang (ORCID: https://orcid.org/0000-0003-3320-677X)
- Rui Guo (ORCID: https://orcid.org/0000-0001-8039-2611)
Institutions
- National Medical Products Administration (CN)
- Ministry of Education (ET)
Publication Details
- Journal
- Bone
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1016/j.bone.2025.117426
- Citations
- 4
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 4.18
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China